Reviva Pharmaceuticals Holdings, Inc.
RVPH
$0.5385
$0.01853.56%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -3.15% | 51.19% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -7.12% | 4.04% | |||
| Operating Income | 7.12% | -4.04% | |||
| Income Before Tax | 5.94% | -2.76% | |||
| Income Tax Expenses | 53.85% | 10.64% | |||
| Earnings from Continuing Operations | 5.89% | -2.77% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 5.89% | -2.77% | |||
| EBIT | 7.12% | -4.04% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 8.17% | 19.09% | |||
| Normalized Basic EPS | 8.23% | 19.02% | |||
| EPS Diluted | 8.17% | 19.09% | |||
| Normalized Diluted EPS | 8.23% | 19.02% | |||
| Average Basic Shares Outstanding | 2.47% | 26.95% | |||
| Average Diluted Shares Outstanding | 2.47% | 26.95% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||